While the mechanism underlying changes in hepatic insulin clearance is not clearly deciphered, prolonged decrease in HIC has been clearly associated with risks for insulin resistance, dyslipidemia, metabolic syndrome, and CVDs [162,163,164]. This evidence concerns the gene INS and metabolic syndrome.